Small study reignites hope for Alzheimer's treatment
Bill Berkrot, Reuters
Mar. 20, 2015, 7:38 PM
Read more: http://uk.businessinsider.com/r-bio...line-in-early-study-2015-3?r=US#ixzz3V1LFivWJ
Biogen’s Alzheimer’s Drug Impresses in Early Trial
By
Joseph Walker
Updated March 20, 2015 6:00 p.m. ET
A Biogen Idec Inc. drug that targets plaque buildup in the brain slowed cognitive decline in patients with early and mild forms of Alzheimer’s disease in a small, early-stage study, lifting the company’s stock to all-time highs and adding to the debate on how to treat the debilitating disease
Biogen’s drug, also known as “BIIB037,” is designed to help clear the brain of beta amyloid plaques, which many scientists say play a role in causing Alzheimer’s, a progressive, memory-destroying condition associated with older age.
Read more
http://www.wsj.com/articles/biogen-details-data-from-early-stage-alzheimers-drug-study-1426844101
Bill Berkrot, Reuters
Mar. 20, 2015, 7:38 PM
Read more: http://uk.businessinsider.com/r-bio...line-in-early-study-2015-3?r=US#ixzz3V1LFivWJ
Biogen’s Alzheimer’s Drug Impresses in Early Trial
By
Joseph Walker
Updated March 20, 2015 6:00 p.m. ET
A Biogen Idec Inc. drug that targets plaque buildup in the brain slowed cognitive decline in patients with early and mild forms of Alzheimer’s disease in a small, early-stage study, lifting the company’s stock to all-time highs and adding to the debate on how to treat the debilitating disease
Biogen’s drug, also known as “BIIB037,” is designed to help clear the brain of beta amyloid plaques, which many scientists say play a role in causing Alzheimer’s, a progressive, memory-destroying condition associated with older age.
Read more
http://www.wsj.com/articles/biogen-details-data-from-early-stage-alzheimers-drug-study-1426844101